Evidence map›Paper›PMID 28386319›Full record

ArticleAmerican journal of translational research2017

Tetrahydrocurcumin reduces oxidative stress-induced apoptosis via the mitochondrial apoptotic pathway by modulating autophagy in rats after traumatic brain injury.

Yongyue Gao, Zong Zhuang, Shanting Gao, Xiang Li, Zihuan Zhang, Zhennan Ye, Liwen Li, Chao Tang, Mengliang Zhou, Xiao Han and 1 more

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
6.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Neuroprotective Effect of Polyphenol Extracts fromMolecules (Basel, Switzerland) · 2022
    Article
  20. Nutraceuticals as Modulators of Autophagy: Relevance in Parkinson's Disease.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Yongyue GaoDepartment of Neurosurgery, Jinling Hospital, School of Medicine, Nanjing University Nanjing 210002, Jiangsu Province, China.
Zong ZhuangDepartment of Neurosurgery, Jinling Hospital, School of Medicine, Nanjing University Nanjing 210002, Jiangsu Province, China.
Shanting GaoDepartment of General Surgery, Drum Tower Hospital, School of Medicine, Nanjing University Nanjing 210008, Jiangsu Province, China.
Xiang LiDepartment of Neurosurgery, Jinling Hospital, School of Medicine, Nanjing University Nanjing 210002, Jiangsu Province, China.
Zihuan ZhangDepartment of Neurosurgery, Zhongdu Hospital Bengbu 233015, Anhui Province, China.
Zhennan YeDepartment of Neurosurgery, Jinling Hospital, School of Medicine, Nanjing University Nanjing 210002, Jiangsu Province, China.
Liwen LiDepartment of Neurosurgery, Jinling Hospital, School of Medicine, Nanjing University Nanjing 210002, Jiangsu Province, China.
Chao TangDepartment of Neurosurgery, Jinling Hospital, School of Medicine, Nanjing University Nanjing 210002, Jiangsu Province, China.
Mengliang ZhouDepartment of Neurosurgery, Jinling Hospital, School of Medicine, Nanjing University Nanjing 210002, Jiangsu Province, China.
Xiao HanDepartment of Biochemistry and Molecular Biology, Key Laboratory of Human Functional Genomics of Jiangsu Province, Nanjing Medical University Nanjing 210002, Jiangsu Province, China.
Jie LiDepartment of Neurosurgery, Jinling Hospital, School of Medicine, Nanjing University Nanjing 210002, Jiangsu Province, China.
Nanjing General Hospital of Nanjing Military Command · CNNanjing University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tetrahydrocurcumin (THC) has been identified as a multi-functional neuroprotective agent in numerous neurological disorders. Oxidative stress as a result of injury may induce neuronal apoptosis after traumatic brain injury (TBI). Treatment with THC may improve neurological function following TBI by attenuating oxidative stress and apoptosis and by enhancing autophagy. The purpose of this study was to investigate the mechanism of neuroprotection by THC against oxidative stress-induced neuronal apoptosis after TBI. We hypothesized that neuroprotection by THC may involve modulation of autophagy and the mitochondria apoptotic pathway. We used western blot analysis to evaluate the effect of THC on proteins involved in mitochondrial autophagy and apoptosis after TBI. The terminal deoxynucleotidyl transferase dUTP nick end-labeling (TUNEL) assay and immunofluorescence staining were used to confirm the role of THC in apoptosis and autophagy, respectively. THC-induced neuroprotection was assessed by neurological severity scoring (NSS) and by measuring the brain water content. We demonstrated that treatment with THC increased expression of autophagy-associated proteins LC3-II and Beclin-1 at 24 h post-TBI. Treatment with THC also reduced expression of malondialdehyde (MDA) and increased glutathione peroxidase (GPx) activity. Further, treatment with THC attenuated apoptosis by modulating mitochondrial apoptosis and reducing oxidative stress. Treatment with 3-methyladenine (3-MA) mitigated autophagy activation and reversed the inhibitory effect of THC on the translocation of Bax to the mitochondrial membrane. Moreover, treatment with THC improved neurological function and reduced the brain water content in rats after TBI. We concluded that the neuroprotective effects of THC are mediated by enhancing autophagy activation and by attenuation of oxidative stress and apoptosis after TBI, probably by modulating the mitochondrial apoptotic pathway. We suggest that THC may be an effective therapeutic agent to treat TBI.

Indexed as

autophagymitochondrial apoptosis pathwayoxidative stresstetrahydrocurcuminTraumatic brain injury

Identifiers

PMID28386319
PMCPMC5375984
OpenAlexW2981192711

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.